Name of the Institute

Analysis of genes can help in detecting diseases at an early stage as well as in determining new drug targets for therapy. Thanks to extremely powerful data processing, the field holds great promise for advancement. Helmholtz Munich is particularly…

The upcoming DZD workshop will take place in Tübingen on March 22/23 and is organized by the IDM Tübingen. 

Different talks and posters will provide an overview on the latest results and exciting projects.

The German Research Foundation (DFG, Deutsche Forschungsgemeinschaft) awarded Fabian Theis the Gottfried Wilhelm Leibniz Prize – the most prestigious research award in Germany. Fabian Theis is Head of the Computational Health Center at Helmholtz…

For major breakthroughs, the American Diabetes Association (ADA) awards its highest honor, the Banting Medal for Scientific Achievement named after the nobel laureate and discoverer of insulin, Frederick Banting. Helmholtz Munich CEO and Humboldt…

Munich scientists from the fields of proteomics, informatics, and medicine are working together on a large-scale project to investigate the causes of diseases of the central nervous system, how they can be diagnosed, and how treatment can be…

Loitering lung cells and cell death in COPD, female researchers with hijab, and the podcast host's concern after 20 years of cigarette use: the new episode of "Resonator" is an extraordinary conversation about Aicha Jeridi's research at the Institute…

Interdisciplinary cooperation between LMU and Helmholtz Munich supported by Bavarian Research Foundation

Unlike other forms of blood cancer, acute myeloid leukemia (AML) cannot currently be treated with CAR-T cell immunotherapy. The reason is that…

Clinical trials are a milestone in the development of safe and effective drugs and therapies. An antibody developed by Helmholtz Munich is now entering a phase 1 clinical trial. Together with the radiopharmaceutical company ITM Isotope Technologies…

ISEE2026 is coming to Munich!

Verhandlungsverfahren ohne TW

Verhandlungsverfahren ohne TW

Verhandlungsverfahren ohne TW Mrz 23 NovaSeq 6000 SP Reagent Kit v1.5, NovaSeq 6000 SP Reagent Kit v1.5, NovaSeq 6000 S4 Reagent Kit v1.5 ILLUMINA GMBH

Verhandlungsverfahren ohne TW

Verhandlungsverfahren ohne TW

Numerous renowned female researchers work at Helmholtz Munich. Ensuring that female scientists receive the best support for their careers is an important element in promoting excellence.

Sex differences exist in the regulation of energy homeostasis, the organism’s mechanism to keep a stable body weight. Current studies indicate for instance that female mammals, including humans, are better protected against metabolic diseases during…

Verhandlungsvergabe ohne TW

The Paris-Munich Epigenetics Workshop & Symposium organized by Dr. Till Bartke from the Institute of Functional Epigenetics will take place at the Max Planck Institute of Biochemistry in Munich on June 14-16, 2023.

Amyotrophic Lateral Sclerosis (ALS) is a non-curable degenerative disease of the motor nervous system. The cause of the disease is largely unknown: In addition to genetic factors, viruses are also suspected to be involved in the development of the…

COPD or pulmonary fibrosis - many chronic lung diseases develop in old age or worsen drastically in the later years of life. Which processes, which molecular processes play a role here? Prof. Dr. Mareike Lehmann, since 2020 group leader at the…

With this new campaign, scientists want to raise awareness for early detection and prevention of type 1 diabetes in children.

Offenes Verfahren nach VOB/A §3EU

Eröffnungstermin: : 23.03.2023 14:00 Uhr

Artificial intelligence is increasingly shaping our daily lives. From digital assistants on cell phones to complex systems in mobility or industrial production - it is impossible to imagine life without this key technology.

LHI/CPC group leader Theodoros Kapellos will have a great opportunity for international scientific exchange this year 2023. He applied for a short-term research fellowship at the European Respiratory Society (ERS) and was accepted.

On January 1, 2023, the new independent research unit “Signaling & Translation” (SAT) was established at Helmholtz Munich under the leadership of Daniel Krappmann. As part of the “Molecular Targets and Therapeutics Center” (MTTC), SAT investigates…

Verhandlungsvergabe ohne TW

Verhandlungsverfahren ohne TW 04.04.2023 - 31.12.2024

Identification of a previously unknown function of adipose tissue in insulin secretion.

Scientists at Helmholtz Munich and the University of Augsburg have made an important breakthrough in better understanding early processes in the development of…

Type 2 diabetes disease progression and successful intervention depend on individual’s unique clinical, genetic, genomic, and environmental information partly represented by gene expression patterns. An international team of researchers around…

The Bavarian State Government appoints Helmholtz Munich researcher Claudia Traidl-Hoffmann as special representative for climate resilience and prevention. The Bavarian Minister of Health, Klaus Holetschek, will present the special representative and…

The campaign “Women@HelmholtzMunich” aims to increase the visibility of women in science and to empower and support women at Helmholtz Munich in their work. With a series of events and social media presence, the campaign will be running between the…

Helmholtz Munich researcher Dr Vincent Fortuin is one of the young investigator group leaders at Helmholtz AI. His work focuses on the interface between Bayesian inference and deep learning. Bayesian inference is a statistical method to learn from…

Non-alcoholic fatty liver disease (NAFLD) is an important risk factor for type 2 diabetes and cardiovascular diseases. In a Perspective in Cell Metabolism, Norbert Stefan from Helmholtz Munich, the German Center for Diabetes Research and the…

Modern cancer therapy aims to tailor treatment to each individual patient's needs by identifying specific molecular targets with essential functions in the tumor of these patients. Leukemia, or blood cancer, is a common tumor in children and occurs…

Before a cell divides, the genomic content of a cell is duplicated during DNA replication. Each cell has many origins of replication (ORIs), but not all are active at the same time, and some fire earlier and some later. Combining their approach to…

Am Freitag, dem 03.02.2023, konnte das HI-MAG sich und seine Arbeit auf der SPIN2030 in der Kongresshalle des Leipziger Zoos mit einem eigenen Messestand in Kooperation mit der Universität Leipzig vorstellen.

How can the clinical translation of research findings be accelerated to improve human health? What role does bioengineering play in driving the development of medicine and biology solutions? Matthias Tschöp, CEO at Helmholtz Munich and Alexander von…

On January 1, 2023, Prof. Jürgen Behr and Gerolf Schmidl received active support from the field of lung research on the Foundation's Board of Directors of Stiftung Atemweg. Dr. Ali Önder Yildirim, Director of the Instititute of Lung Health and…

The pandemic, war, or climate change are stressful for many people. In response to stress, the body’s own hormones glucocorticoids are released. High stress hormone levels are associated with metabolic disease and aging, whereas dieting might…

Mohammad Lotfollahi wins the prestigious Bayer Foundation "Early Excellence in Science Award" in the category "Data Sciences" in Life Sciences for his pioneering machine learning algorithms.

Every year, the Bayer Foundation awards the Early Excellence in Science Award. This year’s winner in the category “Data Science in the Life Sciences” is Helmholtz Munich researcher Mohammad Lotfollahi from the Institute of Computational Biology. With…

How do I stay healthy? What impact do my environment and lifestyle have on my health? And how can I prevent, treat, or even cure chronic diseases like diabetes, allergies, or lung diseases?

Helmholtz Munich researcher Carsten Marr, Director of the Institute of AI for Health, has acquired a European Research Council (ERC) Proof of Concept Grant for his project on the development of LeukoScreen, an AI-based software to automatically…

The Gordon Research Conference "Chromatin Modifications in Health and Disease", co-organised by Robert Schneider, will take place from June 11-16,2023, at Bryant University in Rhode Island. The deadline for abstract submission is on May 14, 2023.

Verhandlungsvergabe ohne TW

Verhandlungsvergabe ohne TW

Verhandlungsvergabe ohne TW

The lab of the Institute of Environmental Health at Helmholtz Munich and the Chair of Environmental Medicine at the University of Augsburg has been awarded a certificate of sustainability.

The SARS-CoV-2 pandemic has challenged public health worldwide. The European project ORCHESTRA - Connecting European Cohorts to Increase Common and Effective Response to SARS-CoV-2 Pandemic - was launched in December 2020 to unite European knowledge…

Blood Bots

By leveraging the power of AI, computers can detect leukemia in blood samples – with accuracy to match their human counterparts

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ergo in gubernando nihil, in officio plurimum interest, quo in genere peccetur. Etiam beatissimum? Duo Reges: constructio interrete. Quod vestri quidem vel optime disputant, nihil opus esse…

Verhandlungsverfahren ohne TW

Verhandlungsverfahren ohne TW

The German Research Foundation funds a new Collaborative Research Centre (CRC)/Transregio (TRR) which aims at employing regulatory T cells to create the basis for tailor-made immunotherapies. This initiative is an alliance of the University Mainz and…

Prof. Dr. med. Dr. h.c. Matthias H. Tschöp has been the Helmholtz Vice President of Health Research since January 2023. His goal is to accelerate the development of new solutions for the health challenges of our time.

muzsmudmudd jrsjzt djz sjs jzrs

Helmholtz Munich scientist Lara Urban has been selected by academics as the Young Scientist of the Year 2022. The academics Young Scientist Award, which is endowed with 5,000 €, honors young scientists who have made lasting advances in their…

Helmholtz AI is a research-driven hub for applied artificial intelligence (AI) and one of five platforms initiated by the Helmholtz Information and Data Science Incubator. Three years after the foundation, Helmholtz AI underwent a review in October…

Matthias Tschöp, CEO of Helmholtz Munich, talks about translating scientific discoveries into clinical practice, about ambitious targets, and about ideas he acquired during his time in the USA.

In a highly competitive procedure, the Group Metabolic Imaging at the IDM was approved by the DFG for 3 years of funding.

The renal phosphate wasting disease X-linked hypophosphatemia (XLH) is a rare metabolic disorder of the bones associated with severe renal phosphate loss. The first symptoms of the genetic defect appear in childhood and adolescence and can…

Verhandlungsverfahren ohne TW

Verhandlungsverfahren ohne TW

Verhandlungsverfahren ohne TW

Week after week, Sven Oswald and Daniel Finger dedicate themselves to a new topic. A medal may have ONE flip side, a topic has COUNTLESS facets. Two on ONE tries to illuminate them. In this episode, Prof. Dr. Andreas Birkenfeld talks about a new…

Congratulations!

Claudia Traidl-Hoffmann was newly appointed to the German Advisory Council on Global Change by the German Federal Cabinet on December 21, 2022.

Verhandlungsverfahren ohne TW

Verhandlungsverfahren ohne TW

Verhandlungsverfahren ohne TW

Verhandlungsverfahren ohne TW

Verhandlungsverfahren ohne TW

Verhandlungsverfahren ohne TW

Verhandlungsverfahren ohne TW

Verhandlungsverfahren ohne TW

Verhandlungsverfahren ohne TW

Verhandlungsverfahren ohne TW

Verhandlungsverfahren ohne TW

Verhandlungsverfahren ohne TW

Verhandlungsverfahren ohne TW

Verhandlungsverfahren ohne TW

Researchers from the Institute for Epigenetics and Stem Cells at Helmholtz Munich studied RNA Polymerase II (Pol II) in early mouse embryos and shed light on transcriptional elongation during zygotic genome activation (ZGA), a key process of…

Researchers from the Institute for Epigenetics and Stem Cells at Helmholtz Munich studied RNA Polymerase II (Pol II) in early mouse embryos and shed light on transcriptional elongation during zygotic genome activation (ZGA), a key process of…

Hepatitis B virus (HBV) infections remain a major global health problem – according to the World Health Organization (WHO) there are around 300 million HBV carriers worldwide. Current treatments rarely succeed in curing the infection. At present,…

How can you trace a single diseased cell in an intact brain or a human heart? The search resembles looking for a needle in a haystack. The teams of Ali Ertürk at Helmholtz Munich and LMU Munich and Matthias Mann at the Max Planck Institute of…

Which factors drive non-communicable inflammatory skin diseases? A research team led by Stefanie Eyerich, Michael Menden, as well as Kilian Eyerich have investigated this question and applied a new spatial transcriptomics technology, that gives…

Medical gaps in the treatment of incurable pulmonary fibrosis: LHI/CPC group leader Prof. Mareike Lehmann explains in the Süddeutsche Zeitung report how lung cells age and sometimes behave like zombies.

In order to treat patients with diabetes in the best possible way it is necessary to understand the disease mechanism. MODY type 3 (MODY3) is a monogenic hereditary form of diabetes, that is caused by a genetic defect in the HNF1A gene. The result is…

Claudia Traidl-Hoffmann was newly appointed to the German Advisory Council on Global Change (WBGU) by the German Federal Cabinet on December 21, 2022. Since the summer of 2022, she has also been a member of the „Environmental Public Health”…

A research team from Helmholtz Munich and the Leipzig University’s Faculty of Medicine has discovered a new mechanism that is associated with severe obesity in children. This genetic rearrangement leads to an unusual expression of a gene that can…

Three approaches with a reputation for slowing aging processes have proven largely ineffective. For their study, researchers developed a new method to measure aging, which accounts for the complexity of aging in organisms.

Klaus Mayer (Director Research Unit Plant Genome and Systems Biology, PGSB) and Michael Schloter (Director Research Unit for Comparative Microbiome Analysis, COMI) are among the 7,000 scientists most cited in 2022. That's according the new list from…

In the perspective article "In preprints: improving and interrogating embryo models", Antonio Scialdone from the Institute for Epigenetics and Stem Cells, the Institute of Functional Epigenetics, and the Institute of Computational Biology at…

In the perspective article "In preprints: improving and interrogating embryo models", Antonio Scialdone from the Institute for Epigenetics and Stem Cells, the Institute of Functional Epigenetics, and the Institute of Computational Biology at…

You are excited about understanding life? You would like to gain hands-on research experience and find out more about the daily life of scientists?

The call for our SUMMER INTERNSHIP PROGRAM 2023 IN EPIGENETICS, STEM CELLS, AND ARTIFICAL…

It is well known that genes and environmental factors such as air pollutants, bacteria and also diet can influence the development of allergies or asthma. Researchers at Helmholtz Munich have now examined the role of food in more detail. Their…

Three approaches with a reputation for slowing aging processes have proven largely ineffective. For their study, researchers developed a new method to measure aging, which accounts for the complexity of aging in organisms.

The Paul G. Allen Frontiers Group, a division of the Allen Institute, announced today the names of the 16 new Allen Distinguished Investigators for 2022. Bilal Sheikh from the Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG)…

The medical technology company Dermagnostix GmbH is a joint spin-off of Helmholtz Munich, the Technical University (TU) Munich and Hahn-Schickard. Its goal: to redefine molecular diagnostics in dermatology. Dermagnostix has now qualified as one of 30…

How is a muscle protein related to energy production in brown adipose tissue (BAT)? And could this be a possible starting point in the fight against obesity? A team of researchers led by John Heiker from the Helmholtz Institute for Metabolic, Obesity…

The Review Board for Medicine of the Deutsche Forschungsgemeinschaft (DFG) has appointed Helmholtz Munich scientist Dr. Marcus Conrad as a new member of the DFG’s Hinterzarten Circle on Cancer Research. Marcus Conrad succeeds Prof. Greten from…

How is a muscle protein related to energy production in brown adipose tissue (BAT)? And could this be a possible starting point in the fight against obesity? A team of researchers led by John Heiker from the Helmholtz Institute for Metabolic, Obesity…

The discovery of gut hormone dual and triple co-agonist drug classes by Matthias Tschöp and Richard DiMarchi has led to a series of new therapeutics in clinical development. The first co-agonist at the receptors for GLP-1 and GIP has recently been…

The cooperation of LMU, Helmholtz Munich, Bundeswehr University and TUM, receives funding for another period of four and a half years.

Helmholtz Munich researcher Boyan Bonev, Principal Investigator of the research group “3D Genome and Molecular Neurobiology” at the Helmholtz Pioneer Campus, is selected as a new EMBO Young Investigator. Today, the European Molecular Biology…

In his testament, a deceased member of the Deutscher Diabetiker Bund (DDB) e. V. stated the will to support diabetes research with 200 000 Euro. The money was now donated to the Institute of Diabetes Research of Helmholtz Munich (IDF) led by…

Through the course of the last several decades, the rate of obesity has progressively increased and is now one of the leading causes of death worldwide – according to the World Health Organization (WHO) 650 million adults are classified as obese. The…

Through the course of the last several decades, the rate of obesity has progressively increased and is now one of the leading causes of death worldwide – according to the World Health Organization (WHO) 650 million adults are classified as obese. The…

Data Science can help save lives. Julia Schnabel talked about the potential of machine learning solutions for medical imaging applications, such as early detection of diseases.

When a cell divides, the correct distribution of cellular content, such as RNAs, to daughter cells is essential. By tagging RNAs with the new diSpinach aptamer in combination with a self-made microfluidics device, researchers at the Institute of…

We introduce a new gene reporter system (INSPECT) that encode reporter or effector proteins from intronic information.

New biological tool for tracking cellular processes

Cells must continuously adjust to their environments and cope with changing temperatures, stress conditions, or resources. Particularly, if conditions change repeatedly, it might make sense for cells to adjust more effectively. A collaborative…

Cells must continuously adjust to their environments and cope with changing temperatures, stress conditions, or resources. Particularly, if conditions change repeatedly, it might make sense for cells to adjust more effectively. A collaborative…

Anlässlich des Weltdiabetestages am 14. November wurden Kathrin Landgraf und Robert Stein, die beide in der Arbeitsgruppe von Antje Körner im Pädiatrischen Forschungszentrum der Universitätsmedizin Leipzig tätig und Gastwissenschaftlerin bzw.…

The researchers Adam C. O’Neill, Fatma Uzbas, Giulia Antognolli and Florencia Merino as well as Magdalena Götz at Helmholtz Munich and Ludwig-Maximilians-University Munich (LMU) receive the “GSCN 2022 Publication of the Year Award” for their joint…

Does exercise help against diabetes and obesity? Researchers around PD Dr Stephanie Kullmann from Helmholtz Munich and DZD have investigated this question in a clinical study. The results show that just eight weeks of exercise can help restore the…

The fourth epigenetics@HelmholtzMunich retreat took place on November 7th – 8th 2022 close to Lake Ammersee in Bavaria.

The fourth epigenetics@HelmholtzMunich retreat took place on November 7th – 8th 2022 close to Lake Ammersee in Bavaria.

The fourth epigenetics@HelmholtzMunich retreat took place on November 7th – 8th 2022 close to Lake Ammersee in Bavaria.

„Everyone’s health is at the mercy of fossil fuels” is the central finding of this year’s Lancet Countdown on Health and Climate Change report. In this report, which was released on October 26th 2022, experts warn of health consequences of the…

„Everyone’s health is at the mercy of fossil fuels” is the central finding of this year’s Lancet Countdown on Health and Climate Change report. In this report, which was released on October 26^th 2022, experts warn of health consequences of the…

Inspired by recent work from Antonio Scialdone’s group on the spatial expression of olfactory neurons, Maria Elena Torres Padilla and Robert Schneider, directors of IES and IFE respectively, teamed up with the Deutsches Museum to share our research…

How do single cells communicate in a tissue? How can these interactions be modeled, while retaining information of spatial context? Researchers around Fabian Theis from Helmholtz Munich Computational Health Center and Technical University of Munich…

More than three percent of the world’s population (around 300 million people) are living with a chronic hepatitis B virus (HBV) infection. Having chronic hepatitis B increases the risk for patients to develop liver failure, liver cancer or cirrhosis…

The sixth Munich Epigenetic Spotlight meeting was held at the Stem Cell Center of Helmholtz Munich in Großhadern on Monday 24th October 2022. Keynote speakers were Eileen Furlong from EMBL, Heidelberg, and Yang Shi from the Ludwig Institute for…

Fabian Theis and Ele Zeggini's interview

Timo Müller and his team have been working for many years on the development of new therapeutic options for diabetes and obesity. Among other things, they decoded a brain receptor that plays a crucial role in the regulation of body weight and food…

The first 'Helmholtz Summer School on Chromatin Biology: A hands-on-expedition', organized by the Institute of Epigenetics and Stem Cells (IES) and the Institute of Functional Epigenetics (IFE) in collaboration with Abcam, took place on Campus from…

We are delighted to announce and warmly welcome Dr. Marion Jasnin as new Principal Investigator at the Helmholtz Pioneer Campus.

Lukas Schwalb and his colleagues have succeeded in chemically describing the complex medical substance sodium bituminosulfonate (SBS) as well as its process intermediates. For this study they have involved the online derivatization with…

Prof. Cristina García-Cáceres (second left) receives the DAG research award 2022 for her scientific contribution in the field of obesity research. The prize, she shares with Dr. Anne Lautenbach from the University Clinic Hamburg-Eppendorf, was…

Study provides novel insights on dynamics of blood sugar levels and autoimmunity in early childhood

When and why does type 1 diabetes manifest in children? For the first time, researchers conducted a long-term study on infants and young children…

Helmholtz Munich researchers identify a novel mechanism to modify glucagon receptor signaling outcomes by altering its intracellular localization

“DGfI Young Immunologists Seminar Series”

Since 2016, the annual Summer Internship Program in Epigenetics, Stem Cells, and Artificial Intelligence gives international students the opportunity to work alongside world-leading scientists on original research. Under the supervision of Kurt…

For pioneering research into the development of allergic diseases, Giulia Pagani has received a grant of 61,400 euros from the German Research Foundation (DFG).

Christian Matek, MD, DPhil is the recipient of this year‘s Artur Pappenheim Award of the German Society of Hematology and Medical Oncology (DGHO). The prize was awarded to him during the common annual meeting of the German, Austrian and Swiss…

Over the next five years, the interdisciplinary NEUROCOV consortium will investigate the role of the host-virus interplay in the occurrence of neurological and psychiatric symptoms resulting from COVID-19 as a foundation for new treatment options.

Helmholtz Munich researcher Kristian Unger, head of Translational Bioinformatics at the Department of Radiation Cytogenetics (ZYTO), together with scientists from the LMU Radiation Clinic and the LMU Medical Physics, has developed the AI method…

What exactly are the molecular interactions between the virus causing COVID-19 and its human host? How might our genetic differences cause different disease courses? And how do still-emerging virus variants differ in their host-virus interactions? To…

Offenes Verfahren nach VOB/A §3EU

Surface molecules EGFR and Integrin beta 4 play a key role in this process

Frequently, cancer patients do not die because of their “initial tumor” in a specific organ. Only when individual cells of the primary tumor transform, migrate or colonize…

In September 2022, the art installation "The Garden of Forking Paths" by the artist duo Studio T*SH was revealed at the Helmholtz Diabetes Center. At the end of 2020, Helmholtz Munich launched the "Kunst am Bau" competition. From 125 entries, 15…

The MDSI congratulates the awardees of the MDSI Best Paper of the Year Award 2021. Runner-up goes to first author Mohammad Lotfollahi from ICB!

Offenes Verfahren nach VOB/A §3EU

In October, we kicked off our new project HOPARL at Helmholtz Munich, together with experts and scientists from the Helmholtz Institute for RNA-based Infection Research (HIRI), the Technical University of Munich (TUM), and the University of Würzburg.

Since October 2022, Carolin Daniel heads the new, independent Helmholtz Munich Research Unit ‘Type 1 Diabetes Immunology’ (TDI). Her research, for which she already received numerous awards, focuses on the immunology of diabetes. We talked to her…

Relaunch of our new TOXI Webpage

For the new Helmholtz Munich Pioneer Campus, an art-on-building competition was held - and the winner has now been announced. Ten artists were asked for creative ideas as part of the anonymous and non-open competition. The goal was to find an…

The ability to reprogram cells holds great promises for regenerative medicine. Cells from the embryo at the beginning of life divide and produce all cell types in the body. What can embryos teach us so that we can generate cells ‘à la carte’ to cure…

They fit in the palm of your hand – tiny mini-labs that researchers at Helmholtz Munich want to use to shape the medicine of tomorrow. “Organ-on-chip” is the key word. This approach combines engineering and biology, not only making it easier to…

Diabetes research: At this year's congress of the European Association for the Study of Diabetes (EASD), Helmholtz Munich scientists received several awards for pioneering ideas and ways to fight the disease.

Kl-based federated diagnostic algorithm efficiently learns across hospitals with data protection compliance

Helmholtz Zentrum München
Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
Ingolstädter Landstraße 1
85764 Neuherberg 
Deutschland

Schwelle:                 UVgO

Vergabeart:              Verhandlungsverfahren ohne TW

Laufzeit:         …

Helmholtz Zentrum München
Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
Ingolstädter Landstraße 1
85764 Neuherberg 
Deutschland

Schwelle:                 UVgO

Vergabeart:              Verhandlungsverfahren ohne TW

Laufzeit:         …

Helmholtz Zentrum München
Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
Ingolstädter Landstraße 1
85764 Neuherberg 
Deutschland

Schwelle:                 UVgO

Vergabeart:              Verhandlungsverfahren ohne TW

Laufzeit:         …

Helmholtz Zentrum München
Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
Ingolstädter Landstraße 1
85764 Neuherberg 
Deutschland

Schwelle:                 UVgO

Vergabeart:              Verhandlungsverfahren ohne TW

Laufzeit:         …

Helmholtz Zentrum München
Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
Ingolstädter Landstraße 1
85764 Neuherberg 
Deutschland

Schwelle:                 UVgO

Vergabeart:              Verhandlungsverfahren ohne TW

Laufzeit:         …

Helmholtz Munich has been participating in the DigiMed Bayern project of the Bavarian State Ministry of Health and Care (STMGP) since the end of 2018. The goal of the project is to advance digitized medicine in Bavaria. The project has now been…

At the 9th Immunotherapy of Cancer Conference (ITOC), held September 22 to 24, 2022 in Munich, Helmholtz Munich presented preclinical data showing that PH-762, an INTASYL compound targeting PD-1, increases the frequency of a T cell population…

Alexander Jais leading the Junior Research Group Diet-Induced Metabolic Alterations at HI-MAG has received a Future Leaders Award from the European Foundation for the Study of Diabetes (ESFD)/Novo Nordisk Foundation.

Researchers at Helmholtz Munich are working toward a world without diabetes. They are not doing so alone, but with a network of organizations, hospitals, and pharmaceutical companies. Their goal is to use experts’ knowledge to create something new:…

A team of researchers located at Helmholtz Munich reports on a novel function of vitamin K, which is generally known for its importance in blood clotting. The researchers discovered that the fully reduced form of vitamin K acts as an antioxidant…

A team of researchers located at Helmholtz Munich reports on a novel function of vitamin K, which is generally known for its importance in blood clotting. The researchers discovered that the fully reduced form of vitamin K acts as an antioxidant…

Rising temperatures accelerate processes: The simple rule of thumb taught in chemistry classes and known as reaction velocity-temperature-regulation, also applies in a broader sense to the effects of global warming on risk groups and sensitive…

New Publication of Ali Doryab and Otmar Schmid (Schmid Lab, Institute of Lung Health and Immunity) in Advanced Materials

Publication of Ali Doryab and Otmar Schmid (Schmid Lab, LHI) in Advanced Materials

Adrian Fischer, PostDoc at IRBM, received the Helmholtz Munich Best Paper Award (Q2, 2022). He took first place as co-first author of the paper "Neutrophils direct preexisting matrix to initiate repair in damaged tissues" published in Nature…

On September 9 Sonja Heine from the Lab Blank (Molecular & Translational Allergology Group) was awarded the Joachim Ganzer Award for Allergen Immunotherapy at the German Allergy Congress in Wiesbaden, Germany.

Dr. Sarah Kim-Hellmuth, Research Group Leader at the Helmholtz Munich Institute of Translational Genomics will be awarded the Friedmund Neumann Prize 2022 for her groundbreaking work in studying the genetic influence on human gene activity.

New IDC publication by Marcos Rios Garcia, Stephan Herzig and Mauricio Berriel Diaz et al.:

Trip13 depletion in liver cancer induces a lipogenic response contributing to Plin2-dependent mitotic cell death.

New IDC publication by Marcos Rios Garcia, Stephan Herzig and Mauricio Berriel Diaz et al.:

Trip13 depletion in liver cancer induces a lipogenic response contributing to Plin2-dependent mitotic cell death.

Helmholtz Munich was present at the Superbloom Festival on the 3rd and 4th of September at the Olympiapark grounds in Munich.

During her stay in August 2022, Anna Dumitriu ran a workshop with researchers at the Institute for Epigenetics and Stem Cells to share her thoughts and experiences of the creative process underlying her artwork “The Cellular Reprogramming Necklace”.

At Helmholtz Munich, scientists are working to ensure that no child will have to suffer from the autoimmune disease type 1 diabetes in the future.

A team of researchers from Helmholtz Munich, the German Center for Diabetes Research (DZD) and Novo Nordisk have developed a new hormone combination for the future treatment of type 2 diabetes. The scientists have combined the blood sugar-reducing…

Parkinson's disease, formerly known as shaking palsy, is the second most common neurodegenerative disease in Germany after Alzheimer's disease. It affects about 400,000 people in Germany alone and can neither be cured nor can its progression be…

The use of artificial intelligence (AI) in the field of pathology, especially in the early detection of diseases, has increased rapidly in the past decade. However, despite an ever-growing number of publications in the field, only few methods are…

Detailed characterization of human pancreatic islets is key to elucidate the pathophysiology of all forms of diabetes mellitus, including its most common form known as type 2 diabetes (T2D). However, access to pancreatic islets is limited and…

Over the last 60 years, research has shed light on histone PTMs and their role in all DNA-templated processes. In the last decade, novel methodologies, such as genome-wide sequencing approaches, have paved the way toward understanding how their…

Even though deep learning has led to improvements, the downstream analysis of live-cell microscopy images remains a bottleneck. Recently, researchers from the Institute of Functional Epigenetics published their open-source and user-friendly software…

Prof. Dr. Anette-Gabriele Ziegler, Director of the Helmholtz Munich Institute of Diabetes Research (IDF) receives this year’s EASD–Novo Nordisk Foundation Diabetes Prize for Excellence. The prize is awarded to honor outstanding contributions to the…

Cardiomyopathy is not a uniform disease. Rather, individual genetic defects lead to heart failure in different ways, an international consortium with participation of Dr. Matthias Heinig, researcher at Helmholtz Munich, reports in Science.

A team of researchers located at Helmholtz Munich reports on a novel function of vitamin K, which is generally known for its importance in blood clotting. The researchers discovered that the fully reduced form of vitamin K acts as an antioxidant…

On days with high temperatures, people taking certain medications have an increased risk of heart attack: this was found by a team of researchers led by Alexandra Schneider, PhD, research group leader 'Environmental Risks' at the Helmholtz Munich…

As part of the book series ‘Methods in Molecular Biology’, Springer Nature has released the methods and protocols collection ‘Histone Methyltransferases’. The chapter contributed by Till Bartke and colleagues from the Institute of Functional…

How can we predict the distribution of inhaled medical substances on the human body? And how can we do so with alternative methods without animal testing?

To unravel the effects of the newly approved cholesterol lowering drug Bempedoic Acid on the epigenome, Dr. Bilal Sheikh has been awarded a project grant of the 'Deutsche Forschungsgemeinschaft' (DFG). He and his team will receive funding of 271,000…

To unravel the effects of the newly approved cholesterol lowering drug Bempedoic Acid on the epigenome, Dr. Bilal Sheikh has been awarded a project grant of the 'Deutsche Forschungsgemeinschaft' (DFG). He and his team will receive funding of 271,000…

To unravel the effects of the newly approved cholesterol lowering drug Bempedoic Acid on the epigenome, Dr. Bilal Sheikh has been awarded a project grant of the 'Deutsche Forschungsgemeinschaft' (DFG). He and his team will receive funding of 271,000…

Researchers gain a fundamental insight for epitranscriptomics and immune response. The research group around Vigo Heissmeyer and Taku Ito-Kureha of Helmholtz Munich and Ludwig-Maximilians-Universität München has revealed the essential function of m6A…

The German Federal Ministry of Education and Research (BMBF) is funding research of new treatment strategies for preventing tissue ischemia-reperfusion injury (IRI) as part of the FERROPath consortium. Starting in July 2022, the consortium receives…

As part of the collaborative research center (CRC) ‘Chemical Biology of Epigenetic Modifications’ (SFB 1309), Robert Schneider, Director of the Institute of Functional Epigenetics’ at Helmholtz Munich, receives funding from the German Research…

Erika von Mutius, Director of the Environmental Health Center, and her team receive an Advanced ERC Grant for their research on prevention strategies to curb asthma and allergies in children. ERC Advanced Grants are endowed with up to 2.5 million…

The EU grant “PerForM-REACT” supports an infrastructure in the greater Munich area for pandemic management and prevention. Helmholtz Munich will receive new equipment for a biosafety level 3 laboratory where researchers can conduct important studies…

Mr. Xiao Wu successfully defended his doctoral thesis

Experts from academia and the pharmaceutical industry came together at “The Biological Methylation Conference: Fundamental Mechanism in Human Health and Disease” in Catania to share new exciting results about protein and RNA methylations as well as…

Fabian Theis, Director of the Computational Health Center at Helmholtz Munich, has been accepted for membership in the European Molecular Biology Organization (EMBO). Scientists can only be invited to join EMBO on the recommendation of existing…

To unravel the effects of the newly approved cholesterol lowering drug Bempedoic Acid on the epigenome, Dr. Bilal Sheikh has been awarded a DFG project grant..

Simon Blank (Head of the Molecular and Translational Allergology group) contributed to two chapters (Bee Venom Allergy & Vespid Venom Allergy) of the second edition the "EAACI Molecular Allergology User's Guide", the world’s first comprehensive…

Internationally renowned neurobiologist Magdalena Götz is pursuing important leads in her quest to elucidate the causes of neurological diseases. Together with her team at Helmholtz Munich and Ludwig-Maximilians-Universität München, she has gained…

Every year, millions of people fall ill with Chagas or sleeping sickness. Both diseases are caused by parasites that are spreading from tropical countries to Europe. Researchers have discovered a weak spot in those parasites, which may be a key to a…

Many children suffer from asthma or allergies. Early and effective prevention of these diseases is the declared goal of science. Which research strategies do scientists pursue and what part does cow barn play in this story?

aeroHEALTH announces manuscript acceptance from first joint comprehensive study combining biological effects and physical/chemical analysis of anthropogenic and biogenic secondary organic aerosols in "Environment International".

Internationally renowned neurobiologist Magdalena Götz is pursuing important leads in her quest to elucidate the causes of neurological diseases. Together with her team at Helmholtz Munich and Ludwig-Maximilians-Universität München, she has gained…

Congratulations to Anne Loft and Ana Alfaro!

Congratulations to Anne Loft and Ana Alfaro!

Helmholtz Munich scientist Stephanie Kullmann is awarded this year's Ferdinand Bertram Award of the German Diabetes Society (DDG). With this award, the DDG honors her research on the role of central nervous processes in the prevention and treatment…

Helmholtz Munich scientist Stephanie Kullmann is awarded this year's Ferdinand Bertram Award of the German Diabetes Society (DDG). With this award, the DDG honors her research on the role of central nervous processes in the prevention and treatment…

In a highly competitive procedure, 2 Research Training Groups in Tübingen were approved by the DFG for 5 years of funding.

Details here.

The MedtecLIVE Talent Award 2022 is given to bachelor’s and master’s theses that relate to an innovation, improvement, or new application in medical technology along with its entire value chain.

For his outstanding achievements in the research field “Diabetes and Cancer”, the German Diabetes Society (DDG) awards this year's Werner Creutzfeldt Prize to Helmholtz Munich scientist Stephan Herzig.

For his outstanding achievements in the research field “Diabetes and Cancer”, the German Diabetes Society (DDG) awards this year's Werner Creutzfeldt Prize to Helmholtz Munich scientist Stephan Herzig.

Researchers have succeeded in sequencing and characterizing the entire genome of oat. Compared to other cereals and humans, the oat genome architecture is very complex. Scientists from Helmholtz Munich, Lund University and the ScanOats network…

The German Academic Exchange Service (Deutscher Akademischer Austauschdienst – DAAD) is using funding from the Federal Ministry of Education and Research (BMBF) to extend its promotion of young AI talents in Germany.

The German Academic Exchange Service (Deutscher Akademischer Austauschdienst – DAAD) is using funding from the Federal Ministry of Education and Research (BMBF) to extend its promotion of young AI talents in Germany.

The German Academic Exchange Service (Deutscher Akademischer Austauschdienst – DAAD) is using funding from the Federal Ministry of Education and Research (BMBF) to extend its promotion of young AI talents in Germany.

Details here.

The Chris McGuigan Symposium took place on 22 April at Cardiff University’s Main Building. The bi-annual awards ceremony celebrates and rewards the work of three scientists who have made a substantial contribution to the field of drug discovery.

A clinical study confirms the success of a novel technology developed by Helmholtz Munich and the Technical University of Munich (TUM) for the evaluation of the treatment of psoriasis. With the new method, doctors can look deeper into the skin of…

Minaskan N / Wiedemann T ... Pellegata NS. A tumor-borne Ang-2/Tie-2 autostimulatory loop controls tumorigenesis. EMBO Mol Med. 2022 Mar 10:e14364

Minaskan N / Wiedemann T ... Pellegata NS. A tumor-borne Ang-2/Tie-2 autostimulatory loop controls tumorigenesis. EMBO Mol Med. 2022 Mar 10:e14364

FERROPTOSIS: When metabolism meets cell death

23. - 27. April 2023 in Seeon, Germany

Registration

https://academic.oup.com/bib/article/23/2/bbab535/6492643?login=true

G-protein coupled receptor marks bronchiole remodeling by distal Keratin 5+ basal progenitor cells

Fostering interdepartmental and cross-institutional research - congrats to Boyan Bonev for his ERC Consolidator Grant to understand the regulatory logic of lineage specification in the developing cortex.

Prof. Dr. Ralf Zimmermann receives honorary doctorate from the University of Eastern Finland.

This work describes the cell-free production, transient protein-modification, and time-resolved proteomics analysis of bacteriophages targeted against clinically relevant bacteria.

For his outstanding achievements in the research field “Diabetes and Cancer”, the German Diabetes Society (DDG) awards this year's Werner Creutzfeldt Prize to Helmholtz Munich scientist Stephan Herzig.

Postdoc position in the new to establish single-cell and quantitative stem cell biology lab.

We are happy that we have won Simona as a PostDoc at IML.

We are happy that we have won Simona as a PostDoc at IML.

We are happy that we have won Simona as a PostDoc at IML.

We are happy that Hannah will start her PhD thesis with us.

Here she introduces herself in a few words.

We are happy that Hannah will start her PhD thesis with us.

Here she introduces herself in a few words.

Two newly acquired ERC Advanced Grants support the cutting-edge research of Munich Helmholtz scientists Heiko Lickert and Fabian Theis. The researchers are international stars in the fields of diabetes and artificial intelligence. The funding will…

Details here.

Two newly acquired ERC Advanced Grants support the cutting-edge research of Munich Helmholtz scientists Heiko Lickert and Fabian Theis. The researchers are international stars in the fields of diabetes and artificial intelligence. The funding will…

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Non quam nostram quidem, inquit Pomponius iocans; Scrupulum, inquam, abeunti; Itaque ab his ordiamur. Beatus sibi videtur esse moriens.Hic nihil fuit, quod quaereremus. Sed quae tandem ista…

Over the last 60 years, research has shed light on histone PTMs and their role in all DNA-templated processes. In the last decade, novel methodologies, such as genome-wide sequencing approaches, have paved the way toward understanding how their…

Just as we use Google Maps, cells rely on gradient sensing of signal molecules to reach their destination. However, in their case, the destination is the source of the attractant and not the restaurant of choice. Using mathematical models,…

Just as we use Google Maps, cells rely on gradient sensing of signal molecules to reach their destination. However, in their case, the destination is the source of the attractant and not the restaurant of choice. Using mathematical models,…

“Infection immunity in COVID-19 and beyond”

“Infection immunity in COVID-19 and beyond”

Since April we have a new IML member: Maxime di Folco.

We welcome him warmly!

Since April we have a new IML member: Maxime di Folco.

We welcome him warmly!

Since April we have a new IML member: Maxime di Folco.

We welcome him warmly!

The EU funds a new Innovative Training Network (ITN) in the field of DNA replication, cell fate, and cancer with Helmholtz Munich as a beneficiary. The ITN will investigate the role of DNA replication as a determinant of cell fate and cancer.

Details here.

By the use of fetal magnetic resonance imaging (MRI), scientists and physicians from Helmholtz Munich and LMU University Hospital Munich have discovered a reduction in lung volume in fetuses from mothers with an uncomplicated SARS-CoV-2 infection…

The sense of smell is essential for almost all animals. It helps find food, detect dangers, and distinguish between friends and enemies. As the saying goes: You really get up my nose.

Research carried out at Helmholtz Munich has shown that…

The sense of smell is essential for almost all animals. It helps find food, detect dangers, and distinguish between friends and enemies. As the saying goes: You really get up my nose.

Research carried out at Helmholtz Munich has shown that…

Prof. Dr. Julia Schnabel is invited as keynote speaker at MIDL 2022.

Prof. Dr. Julia Schnabel is invited as keynote speaker at MIDL 2022.

Prof. Dr. Julia Schnabel is invited as keynote speaker at MIDL 2022.

At each event, two Principal Investigators (PIs) of MIBE working in related research areas will provide exciting insights into their research. After the talks which take around 90 minutes, there is plenty of time for networking.

At each event, two Principal Investigators (PIs) of MIBE working in related research areas will provide exciting insights into their research. After the talks which take around 90 minutes, there is plenty of time for networking.

At each event, two Principal Investigators (PIs) of MIBE working in related research areas will provide exciting insights into their research. After the talks which take around 90 minutes, there is plenty of time for networking.

Dates: Friday, 25th March 2022 & Saturday 26th March 2022

Location: TranslaTUM, Munich & online

Dates: Friday, 25th March 2022 & Saturday 26th March 2022

Location: TranslaTUM, Munich & online

Dates: Friday, 25th March 2022 & Saturday 26th March 2022

Location: TranslaTUM, Munich & online

Helmholtz Munich obtains two ERC Consolidator Grants: Timo Müller from the Institute for Diabetes and Obesity with "TRUSTED", and Ben Engel, formerly of the Helmholtz Pioneer Campus, with "cryOcean". They are among the successful 12 percent to…

From October 17th to 20th October 2022, the conference "EpIC - EpiGene3Sys meets INC_Spain to ChromDesign the Genome" will take place in Granada, Spain. The registration will open soon.

The Corona pandemic showed us clearly that to be able to find, understand and evaluate good health information is an important prerequisite for protecting ourselves from fake news. It is therefore important to begin by strengthening the health…

Article in Nature Communications: Reduction of PRMT7 protein could stop tissue damage

Replacing sick or damaged cells with healthy cells: this is a major goal of regenerative medicine. One of the most promising approaches is cellular reprogramming, whereby one cell type in our body converts to another cell type. Research carried out…

Details here.

Replacing sick or damaged cells with healthy cells: this is a major goal of regenerative medicine. One of the most promising approaches is cellular reprogramming, whereby one cell type in our body converts to another cell type. Research carried out…

Reversing injury or disease is a major objective in research towards regenerative medicine. Replacing sick or damaged cells with healthy cells in order to repair damaged tissue is one of the most impactful strategies towards that goal. For that, a…

Details here.

It only takes a blood test to detect the autoimmune disease type 1 diabetes in children at an early stage and, thus, prevent severe metabolic derailments. Helmholtz Munich offers the world's largest population-based screening for type 1 diabetes in…

Topic: "Allergic Rhinitis" in BR24 Gesundheitsmagazin

Lukas Heumos and team have won the campusSOURCE Award 2022 for cookietemple tool.

Together with five other Helmholtz centers, we develop solutions for a healthier society in a network of cutting-edge biomedical research that is unique in Europe. Our mission is to translate research results as quickly as possible into advances for…

Voluntary fasting, for example interval fasting, is beneficial to health for many people, depending on their individual condition. For example, controlled periods of starvation can prevent and improve diseases such as diabetes and obesity.…

We are delighted to announce the launch of the "1st Helmholtz Summer School on Chromatin Biology: A hands-on expedition", which will take place at the Neuherberg Campus of Helmholtz Munich, from August 15-26, 2022.

We are delighted to announce the launch of the "1st Helmholtz Summer School on Chromatin Biology: A hands-on expedition", which will take place at the Neuherberg Campus of Helmholtz Munich, from August 15-26, 2022.

Data is not only the answer to numerous questions in the business world; the same applies to biomedical research. In order to develop new therapies or prevention strategies for diseases, scientists need more and better data, faster and faster.…

According to a new study led by Ulrike Protzer, a breakthrough infection after two vaccinations achieves the same protective effect as an additional booster vaccination. According to the study by Helmholtz Munich, LMU and TUM, the decisive factor for…

Squidpy: a scalable framework for spatial omics analysis

Single-cell data in context

Lotfollahi et al. present scArches, a method to contextualize new single-cell datasets within existing reference atlases without the need to share raw data.

Volume 40 Issue 1, January 2022

The Epstein-Barr virus (EBV) has been known for some time to play a part in a range of diseases. A current US study has now shown a close link between EBV and multiple sclerosis. Scientists at Helmholtz Munich and DZIF are already working on…

Medicine is on the verge of another revolution: Artificial intelligence supports doctors in analyzing X-ray and ultrasound images and in improving diagnostics and treatment. Researchers in Germany are also successfully working on novel solutions, and…

Medicine is on the verge of another revolution: Artificial intelligence supports doctors in analyzing X-ray and ultrasound images and in improving diagnostics and treatment. Researchers in Germany are also successfully working on novel solutions, and…

Medicine is on the verge of another revolution: Artificial intelligence supports doctors in analyzing X-ray and ultrasound images and in improving diagnostics and treatment. Researchers in Germany are also successfully working on novel solutions, and…

How AI is revolutionizing medicine

Therapy-resistant head and neck tumors and their relapses exhibit molecular profiles that, as now discovered, indicate marked tumor heterogeneity and molecular dynamics within one patient. The composition of tumor subpopulations influenced by therapy…

The interplay of genetics and epigenetics is a long-sought riddle in the development of diseases. Researchers from Helmholtz Munich and the Imperial College London discovered novel interactions. Their findings improve our knowledge about…

Link to publication.

Helmholtz Munich starts the new year with a triple success: Together with early-career scientists, the research center acquires three ERC Starting Grants from the European Research Council (ERC). The researchers have the vision to discover…

The possibility to generate any cell type from a differentiated, somatic cell can advance cell-replacement therapies and holds great promises to regenerative medicine. Therefore, understanding the molecular mechanisms underlying cell-fate changes…

Link to paper here.

Michael Schloter has been elected a member of the Bavarian Academy of Sciences for the committee “Forum Ecology”. This is the third membership of Helmholtz Munich researchers in the Academy, highlighting the expertise of our scientists and the…

We are delighted to announce the 10th International Workshop on Biomedical Image Registration (WBIR2022) that will be hosted in Munich, Germany, from 10th to 12th July 2022.

We are delighted to announce the 10th International Workshop on Biomedical Image Registration (WBIR2022) that will be hosted in Munich, Germany, from 10th to 12th July 2022.

We are delighted to announce the 10th International Workshop on Biomedical Image Registration (WBIR2022) that will be hosted in Munich, Germany, from 10th to 12th July 2022.

By Anirban Mukhopadhyay

Podcast is a great clinical culture for Knowledge dissemination, constructive arguments & deep discussions. One more way in which the MICCAI community is different from those who we serve. Introducing "AI-ready Healthcare",…

By Anirban Mukhopadhyay

Podcast is a great clinical culture for Knowledge dissemination, constructive arguments & deep discussions. One more way in which the MICCAI community is different from those who we serve. Introducing "AI-ready Healthcare",…

By Anirban Mukhopadhyay

Podcast is a great clinical culture for Knowledge dissemination, constructive arguments & deep discussions. One more way in which the MICCAI community is different from those who we serve. Introducing "AI-ready Healthcare",…

Vaccines against the SARS-CoV-2 virus have been made possible by an unprecedented worldwide partnership. However, medications against Covid-19 have yet seen only partial success. With the support of the Bavarian Research Foundation, a Munich research…

Scientists at Helmholtz Zentrum München have discovered a new signaling mechanism for the regulation of energy metabolism in brown adipose tissue.

Scientists at Helmholtz Zentrum München have discovered a new signaling mechanism for the regulation of energy metabolism in brown adipose tissue.

The artwork "Auf den Schultern von Riesen" (Standing on the shoulders of giants) by Heike Weber and Walter Eul will illuminate the tower of the future conference center on Neuherberg Campus. The artist duo made first place in the competition "Light…

Biomedical imaging is the window through which we can look into organisms. It allows us to see cells, their behavior and localization that would otherwise be hidden. Tracking very few cells over time without damaging them is a key challenge in health…

Das Naturkundemuseum Bayern 'BIOTOPIA' veranstaltete am 2. Dezember ein Online-Event zum Thema "Künstliche Intelligenz im Gesundheitswesen: Anwendungen, Herausforderungen, Zukunftspotenziale". Vom Zentrum mit dabei sind unser CEO Matthias Tschöp,…

Das Naturkundemuseum Bayern 'BIOTOPIA' veranstaltete am 2. Dezember ein Online-Event zum Thema "Künstliche Intelligenz im Gesundheitswesen: Anwendungen, Herausforderungen, Zukunftspotenziale". Vom Zentrum mit dabei sind unser CEO Matthias Tschöp,…

Das Naturkundemuseum Bayern 'BIOTOPIA' veranstaltete am 2. Dezember ein Online-Event zum Thema "Künstliche Intelligenz im Gesundheitswesen: Anwendungen, Herausforderungen, Zukunftspotenziale". Vom Zentrum mit dabei sind unser CEO Matthias Tschöp,…

For the first time, scientists based at Helmholtz Munich and the University of Oxford were able to shed light on one of the most critical stages of human embryonic development (gastrulation). The finding, published in the journal Nature, will…

How can we better diagnose blood diseases? A research group led by Helmholtz Munich aims to answer this question with artificial intelligence (AI). Their goal is to facilitate the time-consuming analysis of bone marrow cells under the microscope. The…

Presentation of the Hamburg Science Prize

Obesity, diabetes and gastrointestinal cancer are frequently linked to an unhealthy diet. However, the molecular mechanisms responsible for this are not fully understood. Researchers at Helmholtz Munich have gained some new insights that help to…

„WISSEN.SCHAFFT.GESUNDHEIT“ – unter diesem Motto präsentierten hochrangige Vertreter:innen des Zentrums am Donnerstag, 18. November, im IMAX-Kino des Deutschen Museums unsere Vision und Forschungshighlights der Öffentlichkeit.

„WISSEN.SCHAFFT.GESUNDHEIT“ – unter diesem Motto präsentierten hochrangige Vertreter:innen des Zentrums am Donnerstag, 18. November, im IMAX-Kino des Deutschen Museums unsere Vision und Forschungshighlights der Öffentlichkeit.

„WISSEN.SCHAFFT.GESUNDHEIT“ – unter diesem Motto präsentierten hochrangige Vertreter:innen des Zentrums am Donnerstag, 18. November, im IMAX-Kino des Deutschen Museums unsere Vision und Forschungshighlights der Öffentlichkeit.

For the first time, scientists based at Helmholtz Zentrum München and the University of Oxford were able to shed light on one of the most critical stages of human embryonic development (gastrulation). Their findings will drive future studies to…

For the first time, scientists based at Helmholtz Zentrum München and the University of Oxford were able to shed light on one of the most critical stages of human embryonic development (gastrulation). Their findings will drive future studies to…

Just in time for World Diabetes Day, the national diabetes information portal www.diabinfo.de has announced that it has expanded its content offering. In addition to German and Turkish, information for people with diabetes and diabetes prevention is…

The 100th anniversary of the discovery of insulin is a milestone in diabetes research and insulin continues to be a lifesaver for many people. At the same time, the International Diabetes Federation predicts a rise in the number of diabetes cases to…

Horst Zitzelsberger and Daniel Samaga from the Research Unit Radiation Cytogenetics, together with researchers from the LMU Hospital and the former Clinical Cooperation Group "Personalized Radiotherapy in Head and Neck Tumors", succeeded in renewing…

Germany is not sufficiently prepared for the health challenges posed by climate change. Despite a growing awareness among political leaders for the urgency of the situation, concrete measures to avoid climate-related health risks and to combat…

Moritz Thomas, who is pursuing a PhD from the Institute of AI Health’s Marr Lab, has won the first prize for his poster at the 2021 German Stem Cell Network annual conference. The 9th edition of the conference, which took place from October 6-8, was…

Understanding cellular architecture is essential for understanding biology. Electron microscopy (EM) uniquely visualizes cellular structures with nanometer resolution. However, traditional methods, such as thin-section EM or EM tomography, have…

Vasilis Ntziachristos receives this year's Karl Heinz Beckurts Prize for his outstanding achievements and pioneering work in the field of biomedical imaging. The BioNTech and CureVac founders were also honored with special prizes at the award…

The Academy of Sciences and Humanities in Hamburg is honouring Fabian Theis as a pioneer in the field of Artificial Intelligence in biomedical applications, above all in the area of single-cell biology.

The “Garden of Forking Paths” will be on display in the inner courtyard of the Helmholtz Diabetes Center from April 2022. Yves Peitzner created the design within the "Art in Architecture" competition for new buildings at the campus.

Researchers have designed antibodies as novel therapeutic candidates for the treatment of chronic hepatitis B and hepatocellular carcinoma. Their study in human cell cultures and in living mice showed the elimination of antigen-positive cells and…

RESONATOR - Der Forschungspodcast der Helmholtz-Gemeinschaft mit Holger Klein

RESONATOR - Der Forschungspodcast der Helmholtz-Gemeinschaft mit Holger Klein

RESONATOR - The Helmholtz Association's research podcast with Holger Klein

Pancreatic beta cells produce, store and secrete insulin upon elevated blood glucose levels. However, the highly regulated process of insulin secretion, especially its molecular features and the stimuli behind this process have not yet been fully…

Computer scientist Julia Schnabel is setting up a new institute at Helmholtz Munich. There, she and her team feed AI systems with patient images. The goal of the research: to give doctors more time for their patients.

Informatikerin Julia Schnabel baut ein neues Institut am Helmholtz Zentrum München auf. Dort füttern sie und ihr Team KI-Systeme mit Patientenbildern. Das Ziel der Forschung: Ärztinnen und Ärzten mehr Zeit für ihre Patienten zu geben.

Computer scientist Julia Schnabel is setting up a new institute at Helmholtz Munich. There, she and her team feed AI systems with patient images. The goal of the research: to give doctors more time for their patients.

Prolonged exposure to air pollution can be linked to an increased risk of stroke and coronary heart disease, even when levels are below the limits specified by the EU and WHO. This has been shown, among others, by researchers and Helmholtz Zentrum…

Researchers developed a novel artificial intelligence algorithm for clinical applications called “scArches”. It efficiently compares patients’ cells with a reference atlas of cells of healthy individuals. This enables physicians to pinpoint cells in…

Researchers found new genetic risk factors for osteoarthritis and identified novel drug targets. Their finding is a milestone towards the development of the first ever curative treatment for osteoarthritis. The study involved an international…

T cells play a decisive role in fighting the coronavirus and preventing infected individuals from becoming seriously ill. They identify and fight the virus directly within the infected cells. A team of researchers working in Munich have produced a…

Computer scientist Julia Schnabel is working on artificial intelligence that can help doctors diagnose and detect serious diseases at an early stage. She is now setting up a new institute at Helmholtz Munich after several decades in England.

Die Informatikerin Julia Schnabel arbeitet an Künstlicher Intelligenz, die Ärzten bei der Diagnose und Früherkennung schwerer Erkrankungen helfen kann. Am Helmholtz Zentrum München baut sie sie jetzt nach mehreren Jahrzehnten in England ein neues…

Computer scientist Julia Schnabel is working on artificial intelligence that can help doctors diagnose and detect serious diseases at an early stage. She is now setting up a new institute at Helmholtz Munich after several decades in England.

The "Fit in Gesundheitsfragen" project team at Helmholtz Zentrum München has been awarded the Comenius EduMedia Medal for their e-learning modules on diabetes. The Society for Pedagogy, Information and Media (GPI) awards the medal for outstanding…

The Institute of AI for Health (AIH) and the Munich Leukemia Laboratory (MLL) have agreed on a comprehensive research and development cooperation. The main goal is the implementation of machine learning and artificial intelligence (AI) in various…

For safety reasons, the Standing Committee on Vaccination (STIKO) in Germany recommends that anyone under the age of 60 who initially received a vaccine from AstraZeneca should be given an mRNA vaccine at their second appointment. Up until now, there…

Christian Matek, a physician and physicist at Helmholtz Zentrum München and the Department of Medicine III at LMU University Hospital Munich, received the Vision Zero Award 2021 for his work on computer-assisted leukemia diagnostics.

A newly engineered organoid on chip platform mimics robustly key features of human pancreas development. This is a stepping stone towards reliable diagnostic solutions for early-stage pancreatic cancer. The study was carried out by an…

After a rigorous peer-review process, the board of trustees of Academia Europeae, the pan-European academy of science, humanities, and letters, has elected our Stem Cell expert Prof. Maria-Elena Torres-Padilla. This is a recognition of her standing…

The work of the Scialdone Lab at the Helmholtz Zentrum München and the Rodriguez at the Imperial College elucidates that differences in mitochondrial activity are key determinants for cellular fitness in various contexts, where endogenous cell…

The work of the Scialdone Lab at the Helmholtz Zentrum München and the Rodriguez at the Imperial College elucidates that differences in mitochondrial activity are key determinants for cellular fitness in various contexts, where endogenous cell…

Cellular competition is a crucial quality control process that ensures that the development of an organism relies on healthy cells. Researchers revealed the secrets underlying cell competition and what features can pre-determine whether a cell will…

After a rigorous peer review process, the board of trustees of Academia Europeae, the pan-European academy of science, humanities and letters, has elected the Stem Cell expert Maria-Elena Torres-Padilla as well as the Epigenetics expert Robert…

The German research foundation DFG funds the collaborative research center ‘Chromatin Dynamics’ (SFB 1064) for four more years. Helmholtz Zentrum München, Ludwigs-Maximilians-Universität München, Technical University of Munich and the Max Planck…

Dr. Christian Matek wins the Vision Zero Award 2021 for his valuable research work in the diagnosis and early detection of cancer using artificial neural networks.

Researchers revealed how non-alcoholic fatty liver disease can develop into a life-threatening complication. Their discovery will accelerate the search for therapeutic solutions. The study was led by Helmholtz Zentrum München in collaboration with…

Type-2 diabetes (T2D) defines a cluster of complex pathological states characterized by persistent hyperglycemia, often leading to cardiovascular complications, kidney failure, retinopathy and neuropathies. Affecting more than 450 million people,…

Scientists from Helmholtz Zentrum München revise the current textbook knowledge about gastrulation, the formation of the basic body plan during embryonic development. Their study in mice has implications for cell replacement strategies and cancer…

An international study led by Helmholtz Zentrum München has revealed the structure of a membrane-remodeling protein that builds and maintains photosynthetic membranes. These fundamental insights lay the groundwork for bioengineering efforts to…

For the past decade, Helmholtz Zentrum München has been committed to improving health information and health literacy with its information services. Together with renowned guests from politics and science, the research center discussed the question…

Researchers have succeeded for the first time in demonstrating the role of hypothalamic astrocytes in obesity-related hypertension. In addition, they showed that the hormone leptin is involved in the increase of blood vessels in the hypothalamus of…

Eleftheria Zeggini, founding director of the Institute of Translational Genomics at Helmholtz Zentrum München, has been elected a member of the European Molecular Biology Organization (EMBO). Today, EMBO announced the names of the international…

We have generated a suite of gene reporters, EXSISERS, that self-excise themselves out of the native amino-acid chain of a protein of interest to report on the translation of specific protein isoforms from alternatively spliced mRNA.

Our proteome is much bigger than our genome because one gene produces several variants of proteins called protein isoforms, whose disbalance is implicated in many diseases. A new bioengineered reporter system developed at Helmholtz Zentrum München…

Researchers have been able to prove for the first time that activation of distinct human endogenous retroviruses, which are part of our genome, impair brain development dramatically. This finding could help to advance research into therapies for…

Julia Schnabel has joined the Center as the head of the newly formed Institute of Machine Learning in Biomedical Imaging (IML). The new institute will complement and link into the biomedical imaging and computational health research program at the…

Julia Schnabel has joined the Center as the head of the newly formed Institute of Machine Learning in Biomedical Imaging (IML). The new institute will complement and link into the biomedical imaging and computational health research program at the…

The Jung Foundation for Science and Research awards Matthias Tschöp with the Ernst Jung Prize for Medicine and honors his groundbreaking research on novel therapeutics for obesity and diabetes. The awards given by the Foundation rank among the…

This year, the German Diabetes Society (DDG) honors two researchers with the Ferdinand Bertram Award. One of the winners is the immunologist Carolin Daniel from Helmholtz Zentrum München.

The German Diabetes Society (DDG) awards its highest recognition, the Paul Langerhans Medal, to Martin Hrabĕ de Angelis. The society honors his outstanding achievements in research into the genetic and epigenetic factors of diabetes mellitus as well…

Julia Schnabel has joined Helmholtz Zentrum München as the head of the newly formed Institute of Machine Learning in Biomedical Imaging. The new institute will complement and link into the biomedical imaging and computational health research program…

A small molecule has entered a novel clinical trial for cancer immunotherapy. The molecule inhibits an enzyme called MALT1 that plays a critical role in suppressing immune reactions against tumor cells. Preclinical studies showed that blocking MALT1…

A new algorithm can predict which genes cause cancer, even if their DNA sequence is not changed. A team of researchers combined a wide variety of data, analyzed it with “Artificial Intelligence” and identified numerous cancer genes. This opens up new…

A study by Helmholtz Zentrum München concludes that during the second Corona wave, three to four times more children in Bavaria, Germany were infected with the Corona virus than reported via PCR tests. In addition, the researchers found that about…

A new study uncovers which cell types can be infected by SARS-CoV-2 due to their viral entry factors. The study also suggests that increased gene expression of these viral entry factors in some individuals partially explains the differences of…

An interdisciplinary group of researchers from Munich will help improve earlier, personalized and preventive treatment of mental diseases starting in January 2022. Helmholtz Zentrum München is a member of the group.

This year’s Berthold Medal, the highest recognition of the German Society of Endocrinology (DGE), goes to Professor Matthias Tschöp, who is CEO of Helmholtz Zentrum München and Alexander-von-Humboldt Professor at Technical University of Munich.…

Type 1 diabetes is the most common metabolic disease in children and adolescents worldwide. It can be particularly dangerous as often there is no diagnosis until severe and sometimes life-threatening symptoms have already developed. The new ‘SINT1A‘…

The GIP receptor in the central nervous system plays a crucial role in the regulation of body weight and food intake. This is shown by a recent study by Helmholtz Zentrum München, ETH Zurich and the German Center for Diabetes Research (DZD). The…

In preparation for the implementation of the new 'Institute of AI for Health' (AIH) a scientific workshop will be held on Monday, February 8, 2021.

Researchers have discovered a novel and druggable insulin inhibitory receptor, named inceptor. The latest study from Helmholtz Zentrum München, the Technical University of Munich and the German Center for Diabetes Research is a significant milestone…

Exercise causes the body to release hundreds of different signals that improve our health in many different ways. Now scientists have mapped these intrinsic signals and how they are released by different organs in mice following exercise at different…

The gut plays a central role in the regulation of the body’s metabolism and its dysfunction is associated with a variety of diseases, such as obesity, diabetes, colitis and colorectal cancer that affect millions of people worldwide. Targeting…

Not all prediabetes is the same: In people in the preliminary stages of type 2 diabetes, there are six clearly distinguishable subtypes, which differ in the development of the disease, diabetes risk, and the development of secondary diseases. The…

Microtubules are a part of cytoskeleton and act as highways for the transport of vesicles within the cell. However, their role in insulin transport and secretion is currently under debate. Now, an international team led by scientists of the…

Helmholtz Zentrum München won two ERC Consolidator Grants for pioneering biomedical research in the fields of metabolic health and bioengineering. In 2020, the European Research Council (ERC) awarded the center with a total of eight ERC Grants. This…

The new Lancet Countdown shows that with a changing climate health risks are increasing globally. The Institute of Epidemiology at Helmholtz Zentrum München together with partners proposed policy recommendations in the Lancet Countdown Policy Brief…

In a landmark discovery for global wheat production, Helmholtz Zentrum München together with an international research team has sequenced the genomes for 15 wheat varieties representing breeding programs around the world, enabling scientists and…

Researchers at Helmholtz Zentrum München together with scientists across Europe developed a novel animal-free method to predict the toxic effect of nanoparticles to the human lung. The method aims to enable the safety-by-design development of safer…

The replacement of lost neurons is a holy grail for neuroscience. A new promising approach is the conversion of glial cells into new neurons. Improving the efficiency of this conversion or reprogramming after brain injury is an important step towards…

Researchers at Helmholtz Zentrum München together with LMU University Eye Hospital Munich and the Technical University of Munich (TUM) created a novel deep learning method that makes automated screenings for eye diseases such as diabetic retinopathy…

Chronic obstructive pulmonary disease (COPD) is one of the most common and deadliest diseases worldwide. Until today, COPD is not curable. Researchers at Helmholtz Zentrum München and at the German Cancer Research Center (DKFZ) have now succeeded in…

Asthma impacts millions of children already at a young age. Children growing up on a farm have a lower risk of developing asthma than children not living on a farm. The mechanisms behind this protective farm effect on childhood asthma are largely…

A new study lead by Helmholtz Zentrum München indicates a six-fold higher SARS-CoV-2 exposure rate among children in Bavaria, Germany, than reported cases. This highlights the value of population-based antibody screenings for pandemic monitoring. The…

Researchers at Helmholtz Zentrum München identified specific fat molecules which affect metabolism during cachexia, a cancer-related energy-wasting syndrome characterized by progressive decrease in muscle and fat tissue mass. These fat molecules may…

Researchers from Helmholtz Zentrum München and the University of California, Los Angeles (UCLA), jointly developed new imaging tools to allow non-invasive imaging of distinct structures, like blood vessels, in multicolor and in real-time. The new…

Researchers at Helmholtz Zentrum München and the University of Bochum received this year's Erwin Schrödinger Prize in recognition of their efforts to develop a cure for parasitic diseases such as Chagas disease with a new compound. The prize is…

Researchers at Helmholtz Zentrum München and the Technical University of Munich (TUM) have developed the world’s smallest ultrasound detector. It is based on miniaturized photonic circuits on top of a silicon chip. With a size 100 times smaller than…

The European Lab for Learning and Intelligent Systems (ELLIS) has added ELLIS Munich to its network of independent units performing outstanding basic research in artificial intelligence (AI) and machine learning (ML). The newly-created ELLIS Munich…

Helmholtz Zentrum München is awarded four ERC Starting Grants in the latest funding round of the European Research Council (ERC). All shortlisted projects submitted by early career researchers were successful, marking a novel record for the center.…

The discovery of insulin in 1921 has been one of greatest scientific achievements of the 20th century. Since then, the availability of insulin has shifted the focus of diabetes treatment from trying to keep patients alive to saving and improving the…

Helmholtz Zentrum München is coordinating a European network to train the next generation of researchers in drug development.

The brain plays a major role in controlling our blood glucose levels. In type 2 diabetics this glucose metabolism brain control is often dysfunctional. Genetic components for this phenomenon have so far remained elusive. A group of scientists at…

The study of cellular dynamics is crucial to understand how cells develop and how diseases progress. Scientist at Helmholtz Zentrum München and Technical University of Munich (TUM) created “scVelo” – a machine learning method and open source software…

Every scar tells a story. Sometimes it can be dramatic, dealing with complicated injuries, surgeries and chronic diseases. Dr. Yuval Rinkevich would rather like to tell stories of regeneration, the healing of wounds on skin or organs without much…

German researchers decoded the European maize genome. In comparison to North American maize lines, they discovered variations that underlie phenotypic differences and may also contribute to the heterosis effect. A better understanding of the effect…

Prof. Dr. Matthias Tschöp, CEO of Helmholtz Zentrum München, has been elected a member of the European Molecular Biology Organization (EMBO). Today EMBO announced the names of the international scientists that have been newly elected as members based…

Totipotency is set to become a key tool for research and future medical applications. Finding efficient ways to generate totipotent-like cells is therefore crucial. In a new study, a group of researchers at Helmholtz Zentrum München found that…

Cell reprogramming provides an outstanding opportunity for the artificial generation of stem cells for regenerative medicine approaches in the clinic. As current cell reprogramming methods are low in efficiency, researchers around the globe aim to…

Researchers at Helmholtz Zentrum München and Ludwig-Maximilians-University (LMU) mapped the signaling network in plants and discovered novel insights about how plants process information about their environment. This gives new potential to strategies…

The Helmholtz Zentrum München teams up with Boehringer Ingelheim in an endeavor to identify novel candidates for anti-obesity treatment.

Researchers, politicians and funding bodies find themselves in front of a unique situation and enormous challenge: The mounting pressure to accelerate and intensify efforts to tackle the COVID-19 pandemic while handling the growing threat from all…

Large-scale antibody testing against the new coronavirus SARS-CoV-2 could help to obtain reliable data on infection rates. Screening children for early stages of type 1 diabetes in Bavaria, "Fr1da-plus" will now integrate SARS-CoV-2 antibody testing…

It is not only people with allergies, but also a subgroup of people without one that suffer in spring and have nasal problems from contact with pollen. A new study shows that biomarkers in the nose can predict the severity of the symptoms that will…

The loss of insulin-secreting beta cells by autoimmune destruction leads to type 1 diabetes. Clinical islet cell transplantation has the potential to cure diabetes, but donor pancreases are rare. In a new study, a group of researchers developed an…

Effective on April 1, 2020, the Personal Radiation Dosimeter facility (Auswertestelle – AWST) is transferred to Mirion. The sale of AWST is now finalized. From now on it operates under its new name “Mirion Technologies (AWST) GmbH”.